Bactine Liquid
NDC Package 65197-820-80
Package Information
Bactine (bactine max wound wash) liquids is clean the affected area, apply a small amount of this product on the area 1 to 3 times daily; may be covered with a sterile bandage (let dry first). This formulation utilizes a liquid delivery system. Marketed by Wellspring Pharmaceutical Corporation, this product is identified by NDC 65197-820 and is authorized under FDA application M003.
Identification & Billing
- RxCUI: 1049254 - benzalkonium chloride 0.13 % Topical Solution
- RxCUI: 1049254 - benzalkonium chloride 1.3 MG/ML Topical Solution
- RxCUI: 2475353 - Bactine Wound Wash 0.13 % Topical Solution
- RxCUI: 2475353 - benzalkonium chloride 1.3 MG/ML Topical Solution [Bactine Wound Wash]
- RxCUI: 2475353 - Bactine Wound Wash 1.3 MG/ML Topical Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 65197 - Wellspring Pharmaceutical Corporation
- 65197-820 - Bactine
- 65197-820-80 - 1 BOTTLE in 1 CARTON / 236 mL in 1 BOTTLE
- 65197-820 - Bactine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 65197-820-80 identifies a specific commercial package of 1 bottle in 1 carton / 236 ml in 1 bottle of Bactine Max, a human over the counter drug labeled by Wellspring Pharmaceutical Corporation. This liquid is formulated for cutaneous use and contains benzalkonium chloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Wellspring Pharmaceutical Corporation on April 15, 2023. The current certification is valid through December 31, 2026.
How is this Wellspring Pharmaceutical Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 65197082080. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.